喀什韩式包皮切割手术费用-【喀什华康医院】,喀什华康医院,喀什男科医院检查费用,喀什阴道紧缩专家号申请,喀什哪一家医院看男科好,喀什妇女上环副作用,喀什意外怀孕18天左右该怎么办,喀什勃起后软不下来

Dr. Fauci lied about masks in March Dr. Fauci has been distorting the level of vaccination needed for herd immunityIt isn’t just himMany in elite bubbles believe the American public doesn’t know “what’s good for them” so they need to be tricked into “doing the right thing”— Marco Rubio (@marcorubio) December 27, 2020 332
Each winter, many people wonder whether its worth getting a flu shot while health officials repeatedly warn against not getting one.Now a new study sheds light on the benefit of doing so. Even when the flu shot is just 20% effective it can still reduce US doctor visits due to illness by an estimated 20 million in a single year, the new report published in the scientific journal PNAS (Proceedings of the National Academy of Sciences of the United States) finds.In addition, vaccination also can prevent thousands of hospitalizations and deaths, the study authors estimated based on the average vaccination coverage rate in the United States."Getting vaccinated against influenza is beneficial to the individual and to the community even when the vaccine is of relatively low efficacy," said Burton H. Singer, co-author of the study and an adjunct professor for the Emerging Pathogens Institute at University of Florida in Gainesville.Caused by viruses, flu is a contagious respiratory illness with mild to severe symptoms that can sometimes lead to death. The flu virus evolves rapidly and new viruses circulate in different parts of the world, so each year scientists must reformulate the vaccine. Add to that an imperfect manufacturing process and even a 'good match' formulation may not be as effective as scientists would like.In fact, the Centers for Disease Control and Prevention estimated just 36% effectiveness for the 2017-18 seasonal vaccine as of February 3. (The season ends in May.)For the new study, Singer and his colleagues created a mathematical model of flu transmission and vaccination to evaluate how much illness is prevented by even a very low effectiveness flu vaccine. The research team found that at the average rate of US coverage even a poor vaccine would prevent a significant amount of illnesses, hospitalizations and deaths.For example, at just 43% coverage (the average rate of Americans who received a flu shot for the years 2012 through 2017), a vaccine with just 20% effectiveness could avert more than 20 million infections or illnesses as compared to not getting the vaccine. In addition, 129,000 hospitalizations and 61,000 deaths could be prevented.Based on the model, if more people got a flu shot, say half of the US population, the same 20% effective flu shot would prevent an additional 3.63 million infections, 21,987 hospitalizations and 8,479 deaths."When a vaccine is fully effective on 50% or more of the people who are vaccinated, you need to primarily focus on vaccinating young children," said Singer. The reason? Children are still building immunity and they pass germs around at school."As efficacy of the vaccine decreases, it becomes increasingly important for the elderly to be vaccinated in addition to young children," said Singer, since the elderly are more likely to develop complications from the flu, such as pneumonia, which can be deadly.The CDC reported a total of 160 flu-related deaths in children and 30,064 flu-related hospitalizations overall?between October 1, 2017 and April 21, 2018. The highest rate of hospitalization occurred among adults 65 years old and older.Richard Webby, a flu scientist who is part of the World Health Organization's advisory board and a member of St. Jude Children's Research Hospital's Department of Infectious Diseases, said "effectiveness estimates go up and down based on a number of factors including match of vaccine and circulating strain and probably other factors we don't fully understand.""The take home message from the past few seasons is that there is much room for improvement," said Webby, who was not involved in the research.Still, more people, particularly the elderly, need to get vaccinated even when the vaccine effectiveness is lower than hoped, Webby said: "This study suggests that even with a less than optimal vaccine there is still much public health benefit that can be achieved if these are used properly and widely." 3992

Dr. Anthony Fauci delivered more good news regarding a potential coronavirus vaccine, indicating some Americans could begin getting vaccinated by the end of this month.During an interview with CNN’s Wolf Blitzer, Fauci, the director of the National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases, said it’s possible a vaccine could begin reaching some Americans by the end of the month, but was confident some would begin getting vaccinated by the end of the year.Fauci’s declaration came on the same day Pfizer said that its Phase 3 vaccine candidate was showing an effectiveness of over 90%. Fauci said the announcement was promising, but a few more questions need to be addressed before it is given approval. Fauci said that things like the vaccine’s durability and effect on the elderly are among concerns that still need to be tackled.“We may have doses that we’re able to give to people by the end of November, beginning of December,” Fauci told CNN’s Blitzer. “Now you have to go through the hoops of making sure all of the I’s are dotted and the T’s are crossed about the safety and regulatory aspects of it, but we would be giving vaccine, very likely, by the end of this year. That is good news.”Last month, the FDA put into place guidelines on approving a vaccine, which was more restrictive than what the White House had hoped for. The FDA noted that a vaccine candidate must be at least 50% effective. Vaccine candidates should include a median follow-up duration of at least two months after completion of the full vaccination regimen to help provide adequate information to assess a vaccine’s risk-benefit.“In addition to outlining our expectations for vaccine sponsors, we also hope the agency's guidance on COVID-19 vaccines helps the public understand our science-based decision-making process that assures vaccine quality, safety and efficacy for any vaccine that is authorized or approved,” Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research, said.While it is possible some will begin getting vaccinated in the coming weeks or months, questions remain on how soon a majority of the country will have the opportunity to become vaccinated. The first Americans slated to become vaccinated will be health care workers and people with a high risk of coronavirus complications, such as the elderly and those living in assisted living facilities, according to an NPR report.Given that Pfizer’s vaccine candidate is showing a high level of effectiveness, Fauci called the development “extraordinary.”"We know there's light at the end of the tunnel, but that doesn't mean that we're going to give up the important public health measures that we continually still have to do every single day,” Fauci said.While there is urgency for both public health and economic reasons for a vaccine, some experts have expressed concern over the speed of a vaccine and whether the expedited timeline is long enough to demonstrate efficacy.Even though a vaccine could be ready by year’s end, trials will be expected to continue for over a year to monitor for possible side effects.According to the FDA, a typical Phase 3 trial would take one to three years.“NIH is committed to supporting several Phase 3 vaccine trials to increase the odds that one or more will be effective in preventing COVID-19 and put us on the road to recovery from this devastating pandemic,” said NIH Director Francis S. Collins, M.D., Ph.D. “We also know that preventing this disease could require multiple vaccines and we’re investing in those that we believe have the greatest potential for success.”Pfizer said based on current projections, it expects to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021. 3823
EL CAJON, Calif. (KGTV) — A judge increased bail for the woman accused of hitting a 9-year-old boy with her car and driving away last Thursday. Courtney Webber appeared in court for the very first time since the crash. Webber's bail was increased to 0,000. The 25-year-old is accused of running a red light and hitting the boy, on his bike, as he was crossing the street at the intersection of Sunshine Avenue and West Main Street in El Cajon. The accident happened around 7:30 a.m. The child was on his way to school.RELATED: El Cajon hit-and-run crash suspect found hiding under bedEl Cajon Police used surveillance video near the scene to find Webber. She was located about 12 hours later, hiding under a bed at her mother's Lakeside home. Court documents indicate Webber was on probation for a previous DUI conviction and had a suspended license. The 9-year-old boy hasn't been identified but attorneys tell 10News he is still recovering at a local hospital. His prognosis is unknown, he suffered several facial fractures and a c-3 vertebral fracture.MAP: Track crime happening in your neighborhoodWebber appeared in court via video conference. Her next court date is scheduled for October 18. 1244
EL CAJON, Calif. (KGTV) - The San Diego Sheriff’s Office is investigating how several pounds of narcotics wound up magnetized to a man’s truck.A Mexican citizen who lives in Tijuana but works in El Cajon noticed a strange object in his fender Thursday morning and called authorities.Deputies found 4 packages containing roughly 5 pounds of narcotics hidden underneath the man’s pickup truck.The man’s next door neighbor informed them that they had seen men tampering with the victim’s truck overnight.“It’s our feeling that someone targeted this car because he could cross the border every day with the SENTRI pass and they were probably waiting to collect the narcotics later today,” said Sgt. Tim Chantler of the Sheriff’s office.Drivers with a SENTRI pass can travel in establishes dedicated commuter lanes to and cross the border faster after applying and being prescreened. Deputies are awaiting test results for the drugs but suspect either meth, heroin, or fentanyl.The driver is not considered a suspect as he called 911, according to authorities. “I would be checking my vehicle every day before I cross the border” said Sgt. Chantler, “ because if you get caught at the border you’re going to have a lot of explaining to do.” 1243
来源:资阳报